| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 13 |
| 1 | RITUXIMAB | 13 |
| 2 | AZATHIOPRINE | 10 |
| 3 | MYCOPHENOLATE MOFETIL | 10 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 10 |
| 5 | METHOTREXATE | 8 |
| 6 | METHOTREXATE SODIUM | 8 |
| 7 | NIVOLUMAB | 8 |
| 8 | ADALIMUMAB | 7 |
| 9 | CARBOPLATIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIQUIMOD | 1 | 0.0004 |
| 1 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 2 | BARICITINIB | 1 | 0.0003 |
| 3 | SELENIUM | 1 | 0.0002 |
| 4 | PONATINIB HYDROCHLORIDE | 1 | 0.0002 |
| 5 | SIROLIMUS | 2 | 0.0001 |
| 6 | IPILIMUMAB | 6 | 0.0001 |
| 7 | PEMBROLIZUMAB | 13 | 0.0001 |
| 8 | AZATHIOPRINE | 10 | 0.0001 |
| 9 | BOSUTINIB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 24 | 0.0002 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 2 | Purine Antimetabolite [EPC] | 10 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 4 | Proteasome Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 14 | 0.0000 |
| 9 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |